Roche Diagnostics International AG

Roche Diagnostics International AG, headquartered in Switzerland (CH), currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Roche Holding AG, it inherits climate commitments and initiatives from its parent company.

Roche Holding AG has set ambitious climate targets, which are cascaded down to its subsidiaries, including Roche Diagnostics. The company is committed to reducing its carbon footprint and has engaged with the Science Based Targets initiative (SBTi) to align its emissions reduction strategies with global climate goals. However, specific reduction targets or achievements for Roche Diagnostics International AG have not been disclosed.

In the context of the broader industry, Roche Diagnostics is part of a movement towards sustainability, focusing on reducing greenhouse gas emissions across its operations. The company is actively involved in initiatives such as the Carbon Disclosure Project (CDP) and is committed to transitioning to renewable energy sources, although specific metrics or targets for these initiatives have not been provided.

Overall, while Roche Diagnostics International AG does not currently report specific emissions data, it is aligned with the climate commitments of its parent company, Roche Holding AG, and is part of a larger effort within the healthcare sector to address climate change.